AMGN Today - Aug 10: Guggenheim Raises Price Target
Impossibile aggiungere al carrello
Puoi avere soltanto 50 titoli nel carrello per il checkout.
Riprova più tardi
Riprova più tardi
Rimozione dalla Lista desideri non riuscita.
Riprova più tardi
Non è stato possibile aggiungere il titolo alla Libreria
Per favore riprova
Non è stato possibile seguire il Podcast
Per favore riprova
Esecuzione del comando Non seguire più non riuscita
-
Letto da:
-
Di:
Here’s what happened. Amgen had a pretty chill day, with trading volume right in line with its average. No big swings or wild moves. It’s like everyone was just sitting back, sipping their coffee, and waiting for something to happen.
Now, why the slow day? Well, there’s a mix of stuff going on. Guggenheim just raised their price target for Amgen to $388, thanks to a strong quarter. That’s a good sign, but it seems like investors are still processing all the news from the past week. Amgen jumped about 8% earlier this week after they raised their guidance, which got folks excited. But then, Erste Group Bank came in and lowered their earnings estimates, which kinda threw a wet blanket on the party. So, it’s a bit of good news and bad news swirling around. Nobody really knows why it didn’t pop today, but sometimes the market just does its own thing.
Looking ahead, there’s chatter about Amgen’s pipeline updates. They’re working on some promising stuff that could shake things up in the future. So, that’s something to keep an eye on.
Alright, that’s a wrap for today’s Amgen scoop! Just remember, I’m here for the info and good vibes, not to give financial advice. Catch you later!
adbl_web_anon_alc_button_suppression_t1
Ancora nessuna recensione